miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Endocrinology

• Publication date

  2015-06-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/me.2015-1080PMID 26066330PMCID PMC4518002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minireview: nuclear receptor coregulators of the p160 family: insights into inflammation and metabolism.

  2015cited by this paper
• Integrative analysis of 111 reference human epigenomes

  2015cited by this paper
• Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.

  2014cited by this paper
• Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis

  2014cited by this paper
• Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis

  2014cited by this paper
• Change of pH during excess sludge fermentation under alkaline, acidic and neutral conditions.

  2014cited by this paper
• Steroid receptor coactivator 1 is an integrator of glucose and NAD+/NADH homeostasis.

  2014cited by this paper
• Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.

  2014cited by this paper
• Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.

  2014cited by this paper
• GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex

  2014cited by this paper
• Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.

  2013cited by this paper
• Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug Combinations

  2013cited by this paper
• Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.

  2013cited by this paper
• MicroRNAs and other non-coding RNAs as targets for anticancer drug development

  2013cited by this paper
• Canonical and non-canonical barriers facing antimiR cancer therapeutics.

  2013cited by this paper
• Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays

  2013cited by this paper
• MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications

  2013cited by this paper
• Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells.

  2013cited by this paper
• Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover

  2013cited by this paper
• Research resource: tissue- and pathway-specific metabolomic profiles of the steroid receptor coactivator (SRC) family.

  2013cited by this paper
• The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.

  2013cited by this paper
• MicroRNAs regulate expression of oncogenes.

  2013cited by this paper
• miRBase: annotating high confidence microRNAs using deep sequencing data

  2013cited by this paper
• DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows

  2013cited by this paper
• DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases

  2013cited by this paper
• Regional activation of the cancer genome by long-range epigenetic remodeling.

  2013cited by this paper
• Genetic and molecular characterization of uveal melanoma cell lines

  2012cited by this paper
• Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

  2012cited by this paper
• miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.

  2012cited by this paper
• The Therapeutic Potential of MicroRNAs in Cancer

  2012cited by this paper
• Nuclear receptor coregulators: modulators of pathology and therapeutic targets

  2012cited by this paper
• The Protein Kinase C (PKC)/Protein Kinase D (PKD)/Steroid Receptor Coactivator (SRC)-3 pathway is an important therapeutic target in Gα-mutant Uveal Melanomas

  2012cited by this paper
• NetWalker: a contextual network analysis tool for functional genomics

  2012cited by this paper
• One Decade of Development and Evolution of MicroRNA Target Prediction Algorithms

  2012cited by this paper
• NormaCurve: A SuperCurve-Based Method That Simultaneously Quantifies and Normalizes Reverse Phase Protein Array Data

  2012cited by this paper
• Practical Aspects of microRNA Target Prediction

  2011cited by this paper
• Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.

  2011cited by this paper
• Tumor Suppressor Role for the SPOP Ubiquitin Ligase in Signal-Dependent Proteolysis of the Oncogenic Coactivator SRC-3/AIB1

  2011cited by this paper
• Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs

  2011cited by this paper
• Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling

  2011cited by this paper
• Integrative Genomics Viewer

  2011cited by this paper
• Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state

  2011cited by this paper
• Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy.

  2011cited by this paper
• Supplementary information for Integrative model of genomic factors for determining binding site selection by estrogen receptor α

  2010cited by this paper
• Global characterization of transcriptional impact of the SRC-3 coregulator.

  2010cited by this paper
• Minireview: the SRC family of coactivators: an entrée to understanding a subset of polygenic diseases?

  2010cited by this paper
• Integrative genomic profiling of human prostate cancer.

  2010cited by this paper
• The NIH Roadmap Epigenomics Mapping Consortium

  2010cited by this paper
• Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis.

  2010cited by this paper
• miRNA expression profiling of lung adenocarcinomas: correlation with mutational status

  2010cited by this paper
• Pash 3.0: A versatile software package for read mapping and integrative analysis of genomic and epigenomic variation using massively parallel DNA sequencing

  2010cited by this paper
• Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.

  2010cited by this paper
• Integrative model of genomic factors for determining binding site selection by estrogen receptor-α

  2010cited by this paper
• Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family

  2009cited by this paper
• Survey of Computational Algorithms for MicroRNA Target Prediction

  2009cited by this paper
• A Multimarker Prognostic Assay for Primary Cutaneous Melanoma

  2009cited by this paper
• Androgen modulation of coregulator expression in prostate cancer cells.

  2009cited by this paper
• Nuclear receptor coregulators in cancer biology.

  2009cited by this paper
• Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer

  2008cited by this paper
• miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

  2008cited by this paper
• ConsensusPathDB—a database for integrating human functional interaction networks

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.

  2008cited by this paper
• Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi

  2008cited by this paper
• Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1.

  2008cited by this paper
• The microRNA.org resource: targets and expression

  2007cited by this paper
• MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

  2007cited by this paper
• BTB/POZ domain of speckle‐type POZ protein (SPOP) confers proapoptotic function in HeLa cells

  2007cited by this paper
• SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock.

  2007cited by this paper
• miRBase: the microRNA sequence database.

  2006cited by this paper
• Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor.

  2006cited by this paper
• Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA

  2006cited by this paper
• Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.

  2006cited by this paper
• Steroid receptor coactivator-1-deficient mice exhibit altered hypothalamic-pituitary-adrenal axis function.

  2006cited by this paper
• Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.

  2006cited by this paper
• Natural selection on human microRNA binding sites inferred from SNP data

  2006cited by this paper
• Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.

  2006cited by this paper
• Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.

  2006cited by this paper
• Combinatorial microRNA target predictions

  2005cited by this paper
• Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking.

  2005cited by this paper
• Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• SRC-3 is required for prostate cancer cell proliferation and survival.

  2005cited by this paper
• Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.

  2005cited by this paper
• Modelling Cellular Processes With Python and Scipy

  2004cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• A combined computational-experimental approach predicts human microRNA targets.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Overexpression of the Nuclear Receptor Coactivator AIB1 (SRC-3) during Progression of Pancreatic Adenocarcinoma

  2004cited by this paper
• High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.

  2004cited by this paper
• Human MicroRNA Targets

  2004cited by this paper
• Role of the Steroid Receptor Coactivator SRC-3 in Cell Growth

  2003cited by this paper
• Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.

  2002cited by this paper
• BIOINFORMATICS APPLICATIONS NOTE

  2001cited by this paper
• Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

  2001cited by this paper
• Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.

  1998cited by this paper
• AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

  1997cited by this paper

• Molecular insights for the tumor suppressor role of SPOP in prostate cancer.

  2026cites this paper
• Steroid receptor co-activator 3 and cancer: a hormonal to non-hormonal story.

  2025cites this paper
• Interconnected study of molecular pathways: miR-137 as a central element at the intersection of lipid metabolism and prostate carcinogenesis

  2025cites this paper
• Exploring of miR-155-5p, miR-181b-5p, and miR-454-3p Expressions in Circulating Cell-Free RNA: Insights from Peripheral Blood of Uveal Malignant Melanoma Patients

  2024cites this paper
• Androgen receptor cofactors: A potential role in understanding prostate cancer.

  2024cites this paper
• Genetics and RNA Regulation of Uveal Melanoma

  2023cites this paper
• Epigenetics, endometriosis and sex steroid receptors: An update on the epigenetic regulatory mechanisms of estrogen and progesterone receptors in patients with endometriosis.

  2023cites this paper
• Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer

  2023influential citation
• Recent approaches for the treatment of uveal melanoma: Opportunities and challenges.

  2023cites this paper
• Noncoding RNAs in intraocular tumor patients

  2022cites this paper
• Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?

  2022cites this paper
• Hsa-miR-23a~27a~24-2 cluster members inhibit aggressiveness of breast cancer cells by commonly targeting NCOA1, NLK and RAP1B.

  2022cites this paper
• MicroRNAs as a clue to overcome breast cancer treatment resistance

  2021cites this paper
• miRNA as regulators of prostate carcinogenesis and endocrine and chemoresistance.

  2021cites this paper
• Current molecular and clinical insights into uveal melanoma (Review)

  2021cites this paper
• Histone Acetyltransferase Enzymes (HATs) as Targets for Cancer Therapy

  2021cites this paper
• OTT_A_253946 6351..6359

  2020cites this paper
• The diverse roles of SPOP in prostate cancer and kidney cancer

  2020cites this paper
• Nanotechnologies for enhancing cancer immunotherapy

  2020cites this paper
• A Review of MicroRNA in Uveal Melanoma

  2020cites this paper
• MicroRNAs and Uveal Melanoma: Understanding the Diverse Role of These Small Molecular Regulators

  2020cites this paper
• Emerging roles of microRNAs and their implications in uveal melanoma

  2020cites this paper
• miR-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis

  2020cites this paper
• The Role of Non-Coding RNAs in Uveal Melanoma

  2020cites this paper
• Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives

  2020cites this paper
• The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: current findings and future perspectives.

  2020cites this paper
• miR-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis

  2020cites this paper
• miR-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis

  2020cites this paper
• MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer

  2019influential citation
• Differential microRNA expression profiles determined by next-generation sequencing in three fulvestrant-resistant human breast cancer cell lines

  2019cites this paper
• Clinical Excellence Histone Acetyltransferase Enzymes (HATs) as Targets for Cancer Therapy

  2018cites this paper
• Reprogramming Cells for Synergistic Combination Therapy with Nanotherapeutics against Uveal Melanoma

  2018cites this paper
• The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma

  2018cites this paper
• MicroRNA-434-3p regulates age-related apoptosis through eIF5A1 in the skeletal muscle

  2017cites this paper
• DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.

  2017cites this paper
• Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism

  2017cites this paper
• Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer

  2016cites this paper
• Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer

  2016influential citation
• miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.

  2016cites this paper
• Steroid Hormone Receptor Coregulators in Endocrine Cancers

  2016cites this paper
• MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators

  2015influential citation